Coronary artery bypass grafting in patients with hematological neoplasms.

ABSTRACT:

Background

Coronary artery bypass grafting (CABG) in patients with concurrent coronary artery disease (CAD) and hematological neoplasms presents unique challenges due to immunosuppression, hematologic dysfunction, and coagulopathy. This study aimed to assess the safety and feasibility of CABG in this population and to evaluate factors influencing prognosis.

Methods

This retrospective study included 41 patients with CAD and hematological neoplasms who underwent CABG between 2018 and 2023. Hematological neoplasms were classified into seven categories, and patients were stratified by hematological disease status: stable, disease-free, or progressive. Key perioperative outcomes, graft patency, and survival data were analyzed. Cox regression models identified independent predicto

SUBMITTER: Zhang L 

PROVIDER: S-EPMC12753907 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature